Foamix Pharmaceuticals Ltd. - Ordinary Shares (FOMX): Price and Financial Metrics

Foamix Pharmaceuticals Ltd. - Ordinary Shares (FOMX)

Today's Latest Price: $2.99 USD

0.25 (-7.72%)

Updated Mar 6 7:36pm

Add FOMX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

See all "A" rated Strong Buy stocks

FOMX Stock Summary

  • FOMX's price/sales ratio is 247.01; that's higher than the P/S ratio of 98.81% of US stocks.
  • With a year-over-year growth in debt of 671.55%, NA's debt growth rate surpasses 96.43% of about US stocks.
  • Revenue growth over the past 12 months for NA comes in at -61.03%, a number that bests merely 2.48% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to FOMX, based on their financial statements, market capitalization, and price volatility, are ETON, GERN, RESN, TROV, and VTVT.

FOMX Stock Price Chart Interactive Chart >

Price chart for FOMX

FOMX Price/Volume Stats

Current price $2.99 52-week high $4.84
Prev. close $3.24 52-week low $1.97
Day low $2.90 Volume 1,930,800
Day high $3.44 Avg. volume 596,231
50-day MA $3.94 Dividend yield N/A
200-day MA $3.16 Market Cap 184.13M

Foamix Pharmaceuticals Ltd. - Ordinary Shares (FOMX) Company Bio

Foamix Pharmaceuticals is a clinical-stage specialty pharmaceutical company focused on developing and commercializing its proprietary minocycline foam for the treatment of acne and other skin conditions. The company was founded in 2003 and is based in Rehovot, Israel.

FOMX Latest News Stream

Event/Time News Detail
Loading, please wait...

FOMX Latest Social Stream

Loading social stream, please wait...

View Full FOMX Social Stream

FOMX Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year 0.67%
3-year -50.50%
5-year -58.06%
YTD -10.21%
2019 -7.24%
2018 -40.27%
2017 -45.86%
2016 36.87%
2015 15.69%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7882 seconds.